Jenna Welsh

Historic False Claims Act Enforcement Illustrates Trump Administration's Focus On Healthcare Fraud

Southern District Of New York Allows Certain Investor Claims Against UiPath To Survive Dismissal

First Circuit Adopts Defense-Friendly "But-For" Causation Standard For AKS-Predicated FCA Claims

Florida District Court Concludes FCA's Qui Tam Provision Is Unconstitutional

Court Dismisses Class Action Against Biopharmaceutical Company For Failing To Disclose Progress Of Competitor; Second Circuit Affirms Dismissal Of Putative Class Action Against Allergan; Eleventh Circuit Affirms That "Toxic" Lender Qualified As A "Dealer" Under The Exchange Act Due To High-Volume Trading; Delaware Court Of Chancery Invalidates Governance Rights In Stockholder Agreement